{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T03:03:07Z","timestamp":1789354987372,"version":"build-2803163510"},"reference-count":108,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Research in Autism Spectrum Disorders"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.rasd.2012.05.007","type":"journal-article","created":{"date-parts":[[2012,6,16]],"date-time":"2012-06-16T00:18:09Z","timestamp":1339805889000},"page":"1311-1320","source":"Crossref","is-referenced-by-count":38,"title":["Targeted treatments in autism and fragile X syndrome"],"prefix":"10.1016","volume":"6","author":[{"given":"C. Ka\u011fan","family":"G\u00fcrkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi J.","family":"Hagerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rasd.2012.05.007_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nrg2346","article-title":"Advances in autism genetics: On the threshold of a new neurobiology","volume":"9","author":"Abrahams","year":"2008","journal-title":"Nature Reviews. Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/01.wnl.0000269781.10417.7b","article-title":"Volumetric brain changes in females with fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"69","author":"Adams","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ajhg.2007.09.005","article-title":"Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene","volume":"82","author":"Alarc\u00f3n","year":"2008","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0020","doi-asserted-by":"crossref","first-page":"160L 4","DOI":"10.1016\/j.ajhg.2007.09.015","article-title":"A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism","volume":"82","author":"Arking","year":"2008","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature10658","article-title":"Mutations causing syndromic autism define an axis of synaptic pathophysiology","volume":"480","author":"Auerbach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.rasd.2012.05.007_bib0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1037\/a0021900","article-title":"Change in maternal criticism and behavior problems in adolescents and adults with autism across a 7-year period","volume":"120","author":"Baker","year":"2011","journal-title":"Journal of Abnormal Psychology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajhg.2007.09.017","article-title":"Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders","volume":"82","author":"Bakkaloglu","year":"2008","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1037\/a0021268","article-title":"Trajectories of emotional well-being in mothers of adolescents and adults with autism","volume":"47","author":"Barker","year":"2011","journal-title":"Developmental Psychology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1192\/bjp.bp.108.059345","article-title":"Prevalence of autism-spectrum conditions: UK school-based population study","volume":"194","author":"Baron-Cohen","year":"2009","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2008.10.004","article-title":"Fragile X syndrome: Loss of local mRNA regulation alters synaptic development and function","volume":"60","author":"Bassell","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.rasd.2012.05.007_bib0055","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/nn1765","article-title":"Fragile X syndrome and autism at the intersection of genetic and neural networks","volume":"9","author":"Belmonte","year":"2006","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.rasd.2012.05.007_bib0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2008.063701","article-title":"A pilot open label, single dose trial of fenobam in adults with fragile X syndrome","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11689-011-9074-7","article-title":"Targeted treatments for fragile X syndrome","volume":"3","author":"Berry-Kravis","year":"2011","journal-title":"Journal of Neurodevelopmental Disorders"},{"key":"10.1016\/j.rasd.2012.05.007_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/DBP.0b013e31817dc447","article-title":"Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome","volume":"29","author":"Berry-Kravis","year":"2008","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0535","series-title":"9th Annual International Meeting for Autism Research","article-title":"Arbaclofen for the Treatment of Children and adults with fragile X syndrome: Results of a phase 2 randomized, double blind placebo controlled crossover study","author":"Berry-Kravis","year":"2010"},{"key":"10.1016\/j.rasd.2012.05.007_bib0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jmg.2008.061796","article-title":"Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model","volume":"46","author":"Bilousova","year":"2009","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.brainresbull.2011.08.001","article-title":"Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: Possible implications for the pharmacotherapy of autism spectrum disorders","volume":"86","author":"Burket","year":"2011","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/j.rasd.2012.05.007_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.31887\/DCNS.2009.11.1\/jdbuxbaum","article-title":"Multiple rare variants in the etiology of autism spectrum disorders","volume":"11","author":"Buxbaum","year":"2009","journal-title":"Dialogues in Clinical Neuroscience"},{"key":"10.1016\/j.rasd.2012.05.007_bib0090","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00439-011-1094-6","article-title":"A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder","volume":"131","author":"Casey","year":"2012","journal-title":"Human Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nchembio.78","article-title":"Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila","volume":"4","author":"Chang","year":"2008","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0100","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/hmg\/ddp479","article-title":"Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration","volume":"19","author":"Chen","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0105","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez","year":"2007","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00439-011-1106-6","article-title":"Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder","volume":"131","author":"Chonchaiya","year":"2012","journal-title":"Human Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0115","first-page":"346","article-title":"Pharmacological intervention in Autism: Targeting critical periods of brain development","volume":"2","author":"Chugani","year":"2005","journal-title":"Clinical Neuropsychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9","article-title":"Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children","volume":"45","author":"Chugani","year":"1999","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/01.jcp.0000177667.35016.e9","article-title":"Tetrahydrobiopterin in the treatment of children with autistic disorder: A double-blind placebo-controlled crossover study","volume":"25","author":"Danfors","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","article-title":"FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism","volume":"146","author":"Darnell","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.rasd.2012.05.007_bib0135","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s10803-007-0512-z","article-title":"Parenting stress in mothers and fathers of toddlers with autism spectrum disorders: Associations with child characteristics","volume":"38","author":"Davis","year":"2008","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.rasd.2012.05.007_bib0140","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1542\/peds.2009-0958","article-title":"Randomized, controlled trial of an intervention for toddlers with autism: The Early Start Denver Model","volume":"125","author":"Dawson","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0145","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1469-8749.2002.tb00266.x","article-title":"Fluoxetine response in children with autistic spectrum disorders: Correlation with familial major affective disorder and intellectual achievement","volume":"44","author":"DeLong","year":"2002","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mcn.2009.09.013","article-title":"Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability","volume":"43","author":"De Rubeis","year":"2010","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.rasd.2012.05.007_bib0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11689-011-9087-2","article-title":"Regulation of molecular pathways in the fragile X syndrome: Insights into autism spectrum disorders","volume":"3","author":"De Rubeis","year":"2011","journal-title":"Journal of Neurodevelopmental Disorders"},{"key":"10.1016\/j.rasd.2012.05.007_bib0160","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.nurt.2010.05.001","article-title":"Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex","volume":"7","author":"de Vries","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2008.04.002","article-title":"Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice","volume":"31","author":"de Vrij","year":"2008","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.rasd.2012.05.007_bib0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","article-title":"Decreased expression of the GABAA receptor in fragile X syndrome","volume":"1121","author":"D\u2019Hulst","year":"2006","journal-title":"Brain Research"},{"key":"10.1016\/j.rasd.2012.05.007_bib0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2008.11.075","article-title":"Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor\/ataxia syndrome (FXTAS)","volume":"1253","author":"D\u2019Hulst","year":"2009","journal-title":"Brain Research"},{"key":"10.1016\/j.rasd.2012.05.007_bib0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00213-006-0518-9","article-title":"A retrospective study of memantine in children and adolescents with pervasive developmental disorders","volume":"191","author":"Erickson","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0185","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4088\/JCP.v67n0619h","article-title":"Memantine for disruptive behavior in autistic disorder","volume":"67","author":"Erickson","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0190","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1097\/00004703-200604002-00012","article-title":"Autism spectrum disorders and attention-deficit\/hyperactivity disorder in boys with the fragile X premutation","volume":"27","author":"Farzin","year":"2006","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0195","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/hmg\/ddr122","article-title":"SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function","volume":"20","author":"Fassio","year":"2011","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0200","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1006\/frne.2002.0229","article-title":"The neuroendocrine basis of social recognition","volume":"23","author":"Ferguson","year":"2002","journal-title":"Frontiers in Neuroendocrinology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1469-8749.1997.tb07437.x","article-title":"Possible effects of tetrahydrobiopterin treatment in six children with autism\u2014Clinical and positron emission tomography data: A pilot study","volume":"39","author":"Fernell","year":"1997","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nurt.2010.05.004","article-title":"Tetrahydrobiopterin as a novel therapeutic intervention for autism","volume":"7","author":"Frye","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/hmg\/ddp497","article-title":"Fibroblast phenotype in male carriers of FMR1 premutation alleles","volume":"19","author":"Garcia-Arocena","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0220","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature07953","article-title":"Autism genome-wide copy number variation reveals ubiquitin and neuronal genes","volume":"459","author":"Glessner","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.rasd.2012.05.007_bib0225","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2010.1706","article-title":"Mitochondrial dysfunction in autism","volume":"304","author":"Giulivi","year":"2010","journal-title":"The Journal of the American Medical Association"},{"key":"10.1016\/j.rasd.2012.05.007_bib0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/npp.2011.137","article-title":"Therapeutic strategies in fragile X syndrome: Dysregulated mGluR signaling and beyond","volume":"37","author":"Gross","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/386296","article-title":"The fragile-X premutation: A maturing perspective","volume":"74","author":"Hagerman","year":"2004","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.psyneuen.2011.07.020","article-title":"Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome","volume":"37","author":"Hall","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0245","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archgenpsychiatry.2011.76","article-title":"Genetic heritability and shared environmental factors among twin pairs with autism","volume":"68","author":"Hallmayer","year":"2011","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0250","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1352\/2008.113:427-438","article-title":"Autism profiles of males with fragile X syndrome","volume":"113","author":"Harris","year":"2008","journal-title":"American Journal of Mental Retardation"},{"key":"10.1016\/j.rasd.2012.05.007_bib0255","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/ajmg.a.31286","article-title":"Autistic behavior in children with fragile X syndrome: Prevalence, stability, and the impact of FMRP","volume":"140A","author":"Hatton","year":"2006","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.rasd.2012.05.007_bib0260","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1017\/S1461145702003061","article-title":"Pilot-controlled trail of d-cycloserine for the treatment of post-traumatic stress disorder","volume":"5","author":"Heresco-Levy","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0265","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.biopsych.2011.05.033","article-title":"Decreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation","volume":"70","author":"Hessl","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0270","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with d-cycloserine for social anxiety disorder","volume":"63","author":"Hofmann","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-244X-9-35","article-title":"Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders","volume":"9","author":"Hofvander","year":"2009","journal-title":"BioMed Central Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0280","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.npp.1300021","article-title":"Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0285","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1152\/jn.2001.86.1.321","article-title":"Chemical induction of mGluR5- and protein synthesis\u2014Dependent long-term depression in hippocampal area CA1","volume":"86","author":"Huber","year":"2001","journal-title":"Journal of Neurophysiology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0290","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00401-011-0860-9","article-title":"Widespread non-central nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor\/ataxia syndrome and CGG knock-in mice","volume":"122","author":"Hunsaker","year":"2011","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/j.rasd.2012.05.007_bib0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/35053579","article-title":"The neurobiology of attachment","volume":"2","author":"Insel","year":"2001","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.rasd.2012.05.007_bib0300","doi-asserted-by":"crossref","first-page":"64ra1","DOI":"10.1126\/scitranslmed.3001708","article-title":"Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056","volume":"3","author":"Jacquemont","year":"2011","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.rasd.2012.05.007_bib0305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng1136","article-title":"Paris Autism Research International Sibpair Study. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism","volume":"34","author":"Jamain","year":"2003","journal-title":"Nature Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0310","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajhg.2007.09.011","article-title":"Disruption of neurexin 1 associated with autism spectrum disorder","volume":"82","author":"Kim","year":"2008","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0315","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","article-title":"Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: Citalopram ineffective in children with autism","volume":"66","author":"King","year":"2009","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0320","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"d-Cycloserine augmented exposure therapy for obsessive\u2013compulsive disorder","volume":"62","author":"Kushner","year":"2007","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0325","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2788.2005.00732.x","article-title":"The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders","volume":"50","author":"Lecavalier","year":"2006","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.rasd.2012.05.007_bib0540","series-title":"2011 SSBP abstract","article-title":"A Double Blind, Placebo Controlled Trial of Minocycline in Children with Fragile X Syndrome","author":"Leigh","year":"2011"},{"key":"10.1016\/j.rasd.2012.05.007_bib0330","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.molmed.2010.08.005","article-title":"Potential therapeutic interventions for fragile X syndrome","volume":"16","author":"Levenga","year":"2010","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.rasd.2012.05.007_bib0335","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.rasd.2011.01.023","article-title":"Outcomes in adolescents and adults with autism: A review of the literature","volume":"5","author":"Levy","year":"2011","journal-title":"Research in Autism Spectrum Disorders"},{"key":"10.1016\/j.rasd.2012.05.007_bib0340","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(09)61376-3","article-title":"Autism","volume":"374","author":"Levy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.rasd.2012.05.007_bib0345","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/YPG.0b013e32833a216f","article-title":"Association analysis of CNTNAP2 polymorphisms with autism in the Chinese Han population","volume":"20","author":"Li","year":"2010","journal-title":"Psychiatric Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0350","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.rasd.2009.10.006","article-title":"Autism spectrum disorders with chromosomal abnormalities","volume":"4","author":"Lo-Castro","year":"2010","journal-title":"Research in Autism Spectrum Disorders"},{"key":"10.1016\/j.rasd.2012.05.007_bib0355","first-page":"e1000898","article-title":"Fragile X mental retardation protein regulates proliferation and differentiation of adult neural stem\/progenitor cells","volume":"6","author":"Luo","year":"2010","journal-title":"Public Library of Science Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0360","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/1073858406298918","article-title":"Neurotransmitters and brain maturation: Early paracrine actions of GABA and glutamate modulate neuronal migration","volume":"13","author":"Manent","year":"2007","journal-title":"The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0365","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1542\/peds.2011-0427","article-title":"A systematic review of medical treatments for children with autism spectrum disorders","volume":"127","author":"McPheeters","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0370","first-page":"e26077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"Public Library of Science One"},{"key":"10.1016\/j.rasd.2012.05.007_bib0375","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.biopsych.2011.01.026","article-title":"d-Cycloserine facilitates socially reinforced learning in an animal model relevant to autism spectrum disorders","volume":"70","author":"Modi","year":"2011","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0380","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cell.2008.07.031","article-title":"The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP","volume":"134","author":"Napoli","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.rasd.2012.05.007_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rasd.2012.05.007_bib0390","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.jcp.0000270082.30500.69","article-title":"Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism","volume":"27","author":"Niederhofer","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0395","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10803-009-0722-7","article-title":"Adolescent siblings of individuals with an autism spectrum disorder: Testing a diathesis-stress model of sibling well-being","volume":"39","author":"Orsmond","year":"2009","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.rasd.2012.05.007_bib0400","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1750-3639.2007.00102.x","article-title":"The neurobiology of autism","volume":"17","author":"Pardo","year":"2007","journal-title":"Brain Pathology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0405","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2377-10-91","article-title":"Open-label add-on treatment trial of minocycline in fragile X syndrome","volume":"10","author":"Paribello","year":"2010","journal-title":"BioMed Central Neurology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0410","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist\u2014A review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0415","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuro.2010.04.002","article-title":"Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins","volume":"31","author":"Paul","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0420","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/297153","article-title":"Alterations of GABAergic signaling in autism spectrum disorders","volume":"2011","author":"Pizzarelli","year":"2011","journal-title":"Neural Plasticity"},{"key":"10.1016\/j.rasd.2012.05.007_bib0425","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1176\/appi.ajp.161.11.2115","article-title":"A pilot study of d-cycloserine in subjects with autistic disorder","volume":"161","author":"Posey","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0430","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1523\/JNEUROSCI.0093-05.2005","article-title":"Postadolescent changes in regional cerebral protein synthesis: An in vivo study in the FMR1 null mouse","volume":"25","author":"Qin","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.rasd.2012.05.007_bib0435","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/cercor\/bhp198","article-title":"Cortical anatomy in autism spectrum disorder: An in vivo MRI study on the effect of age","volume":"20","author":"Raznahan","year":"2010","journal-title":"Cerebral Cortex"},{"key":"10.1016\/j.rasd.2012.05.007_bib0440","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: Use of d-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.rasd.2012.05.007_bib0445","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ajmg.b.31159","article-title":"Autism spectrum disorders and autistic traits: A decade of new twin studies","volume":"156B","author":"Ronald","year":"2011","journal-title":"American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0450","series-title":"Aminoacid neurotransmitters. Synopsis of psychiatry","author":"Sadock","year":"2008"},{"key":"10.1016\/j.rasd.2012.05.007_bib0455","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/emboj.2010.21","article-title":"Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients","volume":"29","author":"Sellier","year":"2010","journal-title":"The EMBO Journal"},{"key":"10.1016\/j.rasd.2012.05.007_bib0460","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s10803-006-0307-7","article-title":"Change in autism symptoms and maladaptive behaviors in adolescents and adults with an autism spectrum disorder","volume":"37","author":"Shattuck","year":"2007","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"10.1016\/j.rasd.2012.05.007_bib0465","first-page":"e25340","article-title":"Alteration of plasma glutamate and glutamine levels in children with high-functioning autism","volume":"6","author":"Shimmura","year":"2011","journal-title":"Public Library of Science One"},{"key":"10.1016\/j.rasd.2012.05.007_bib0470","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/npp.2009.201","article-title":"Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP","volume":"35","author":"Silverman","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0475","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.chc.2008.06.003","article-title":"Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders","volume":"17","author":"Soorya","year":"2008","journal-title":"Child and Adolescent Psychiatric Clinics of North America"},{"key":"10.1016\/j.rasd.2012.05.007_bib0480","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11689-010-9047-2","article-title":"Aging in fragile X syndrome","volume":"2","author":"Utari","year":"2010","journal-title":"Journal of Neurodevelopmental Disorders"},{"key":"10.1016\/j.rasd.2012.05.007_bib0485","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1352\/1944-7558-115.5.433","article-title":"Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures","volume":"115","author":"Utari","year":"2010","journal-title":"American Journal on Intellectual and Developmental Disabilities"},{"key":"10.1016\/j.rasd.2012.05.007_bib0490","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.genom.5.061903.180050","article-title":"Autism as a paradigmatic complex genetic disorder","volume":"5","author":"Veenstra-Vanderweele","year":"2004","journal-title":"Annual Review of Genomics and Human Genetics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0495","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1093\/brain\/awq279","article-title":"Age-related temporal and parietal cortical thinning in autism spectrum disorders","volume":"133","author":"Wallace","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.rasd.2012.05.007_bib0500","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nurt.2010.05.005","article-title":"Fragile X: Leading the way for targeted treatments in autism","volume":"7","author":"Wang","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.rasd.2012.05.007_bib0505","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuron.2008.06.027","article-title":"FMRP acts as a key messenger for dopamine modulation in the forebrain","volume":"59","author":"Wang","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.rasd.2012.05.007_bib0510","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature07999","article-title":"Common genetic variants on 5p14.1 associate with autism spectrum disorders","volume":"459","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.rasd.2012.05.007_bib0515","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0006-8993(90)90745-W","article-title":"d-Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes","volume":"510","author":"Watson","year":"1990","journal-title":"Brain Research"},{"key":"10.1016\/j.rasd.2012.05.007_bib0520","first-page":"CD004677","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)","volume":"4","author":"Williams","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.rasd.2012.05.007_bib0525","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/08830738040190090701","article-title":"Autism and tuberous sclerosis","volume":"19","author":"Wiznitzer","year":"2004","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.rasd.2012.05.007_bib0530","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00431-007-0569-x","article-title":"The diagnosis of autism in a female: Could it be Rett syndrome?","volume":"167","author":"Young","year":"2008","journal-title":"European Journal of Pediatrics"}],"container-title":["Research in Autism Spectrum Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175094671200061X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S175094671200061X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T05:29:40Z","timestamp":1642483780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S175094671200061X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":108,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S175094671200061X"],"URL":"https:\/\/doi.org\/10.1016\/j.rasd.2012.05.007","relation":{},"ISSN":["1750-9467"],"issn-type":[{"value":"1750-9467","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}